+63%1
PC-IOL unit sell-out
2024–2025
While total unit sell-out in the same recorded IOL portfolio grew 3%.
Premium IOL Adoption
Premium IOL adoption shouldn't depend on who is in the consultation room.
Your clinic may already have excellent surgeons, premium technology and patients who can afford advanced IOLs.
Yet adoption still varies from surgeon to surgeon, patient to patient and day to day.
The gap is often not technology, price or patient demand. It is how the decision pathway is designed.
Oleksii SologubStrategic Advisor in Premium IOL Adoption
Founder of PDDA® Studio and creator of Patient Decision Design Architecture™ (PDDA®), for private eye clinics and IOL brands.
Documented one-market commercial record · Data on file1
3 in 41
Active partner accounts purchased PC-IOLs
2025
Breadth across the active partner network.
+59%1
PC-IOL volume across repeat accounts
2024–2025
Deeper adoption inside the existing account base.
+40%1
More routine PC-IOL accounts
2024–2025
The number purchasing in at least six months grew 40%.
PC-IOL means presbyopia-correcting IOL. Figures are distributor sell-out — not implantations, clinical outcomes or national market share. Repeat accounts recorded positive annual net PC-IOL sell-out in both years; routine accounts did so in at least six calendar months of a year.
Recognition
When Premium Adoption Underperforms, Technology May Not Be the Problem
A clinic can have excellent surgeons, premium IOL technology, good diagnostics and strong clinical outcomes — and still find that premium adoption stays inconsistent, below its potential, or dependent on factors no one can quite control.
01
Inconsistent Offering
Premium IOL discussion depends too much on the individual surgeon or counselor.
02
Value Is Lost
Patients hear technology benefits but do not clearly see what they mean for their own life.
03
Surgeons Feel They Must Sell
Clinical experts are pushed into a commercial role they may naturally resist.
04
Too Many Choices
An overloaded premium range creates confusion rather than confidence.
05
Expectations Do Not Align
Online expectations, education and the consultation may tell different stories.
06
Good Surgery Can Still Create an Unhappy Patient
A technically successful outcome can still disappoint when the decision never felt owned.
Operational consequence
What This Costs the Clinic
These costs are rarely visible as a single failure. They accumulate quietly — margin, time and patient confidence leak away from a pathway no one has deliberately designed.
- Lower premium adoption
- Variation between surgeons
- Longer consultations
- Patient decision paralysis
- Expectation mismatch
- Missed premium margin
- Staff frustration
- Unhappy patients despite technically successful surgery
The desired state
What a Well-Designed Premium Pathway Looks Like
Before the method, the outcome. This is the operating reality a designed decision pathway should produce.
- 01Patients arrive better prepared.
- 02Surgeons understand what matters to the individual patient.
- 03Premium options are explained consistently.
- 04Benefits and compromises are connected to real patient values.
- 05The surgeon does not need to become a salesperson.
- 06The patient feels ownership of the final decision.
- 07Premium adoption becomes more consistent and measurable.
The PDDA® journey model
One Patient Decision. Two Connected Miles.
In the PDDA® model, the First Mile is everything that frames the decision before the visit. The Last Mile is the clinical conversation where personal value, evidence and trade-offs become a shared choice.
Before the consultation
First Mile
Search & AIClinic contentReferrals & stories
Where expectation meets reality
Clinic Handoff
BookingPre-assessmentFirst human contact
Inside the consultation
Last Mile
Patient valuesOptions & trade-offsShared decision
One designed system
PDDA® connects what shapes the decision before the visit with how the choice is made inside the consultation.
What gets redesigned
The Decision Pathway, Not the Sales Pitch
This is not a communication workshop or a set of sales scripts. It is a system-level redesign of how a premium decision is made — before, inside and across the consultation.
01
Before the Consultation
Align online promise, patient education and expectations — so the patient arrives already framed to understand value.
02
Inside the Consultation
Connect patient values, visual priorities, clinical options and trade-offs — so the conversation is clear, honest and personal.
03
Across the Business
Create consistency across surgeons, staff, communication rules and management metrics — so the pathway no longer depends on individual skill.
The discipline
Design the decision, not the sale.
PDDA® — Patient Decision Design Architecture™ — is the proprietary discipline and architecture behind the work. It connects three layers of the patient decision and applies them through four practical frameworks.
1
Value
What matters to this person's life and vision.
2
Communication
How clinical options and trade-offs are translated into personal meaning.
3
Decision Environment
How uncertainty, fear and cognitive overload are reduced so a shared decision can happen naturally.
For private eye surgery clinics
The Premium Pathway Is a System, Not a Skill
You may already have the technology, the surgeons and the patient demand. The missing element may be how the premium decision journey is designed — consistently, across every surgeon and every consultation.
- More consistent premium offering
- Stronger patient understanding
- Less sales pressure on surgeons
- Better alignment between patient values and technology
- Clearer premium positioning
- More predictable adoption
- Lower expectation mismatch
For IOL brands
Make Your Product Value Survive the Last Mile
A strong clinical claim does not automatically become patient-perceived value. Between a well-engineered IOL and a patient who chooses it, value can leak at any step.
Clinical value
Brand narrative
Clinic
Surgeon
Patient meaning
Decision
- Patient-language strategy
- Value narrative
- Clinic activation
- Patient decision insight
- Premium IOL market development
- Communication architecture
Why this perspective is different
Built Across the Full Premium IOL Value Chain
This is not advisory theory applied to a new industry. It is work since 1996 across the clinic, the industry and the patient side — distilled into a method for the problem that keeps recurring at the senior level.
1996
In ophthalmology since
Market builder
Premium IOL market-building experience
22,700+
IOL questionnaire records · 65+ countries and territories
15M+
Verified YouTube views · two patient-education channels
Business builder before advisor
Founded and led an independent ophthalmic surgical distribution business — operator first, advisor later.
Premium IOL distribution and market development
First-hand experience of how premium technologies move — and where they stall — across real markets.
Decades working with private clinics
Long-term work alongside the clinics where decisions are actually made, at the operational level.
Direct patient research
Years of conversation with cataract and refractive patients, formalised through IOL decision research.
Large direct-to-patient education
More than 15 million verified YouTube views across two patient-education channels, built by translating clinical complexity into patient language.
External recognition
Published and Invited to Speak
Selected independent publications and invited industry appearances — distinct from the original analysis in Insights.
Insights
Strategic Insights
Analysis and field observations on premium IOL adoption, patient decision design, clinic strategy and the last mile of clinical value.
About
First a Business Builder. Then a Strategic Advisor.
The methodology behind this work did not come from theory. It came from building businesses in ophthalmology, developing premium markets, working with clinics and industry, and studying how patients actually decide.
Start the conversation
If premium IOL adoption is strategic for your business, let's talk.
Tell me where you see the problem. A 20-minute call can clarify what is happening and whether there is a useful project to define.